Form 4: UnitedHealth Group CEO Stephen Hemsley Reports Acquisition of Deferred Stock Units
Insider Transaction Report
UnitedHealth Group's CEO and Director, Stephen J. Hemsley, reported the acquisition of 198 common stock shares as deferred stock units for director compensation.
Summary
- Stephen J. Hemsley, who serves as CEO and Director of UnitedHealth Group (UNH), acquired 198 shares of common stock.
- These shares represent deferred stock units granted as regular quarterly compensation for his service as a director of UnitedHealth Group.
- The deferred stock units are immediately vested but must be retained by the director until the completion of his service on the Board.
- Following this transaction, Hemsley's beneficial ownership includes 374,605.942 shares held directly, 349.7176 shares held indirectly via a 401(k), and 735,115 shares held indirectly via trusts.
Sentiment
Score: 7
Explanation: The acquisition of shares by a key insider, even as compensation, generally indicates confidence in the company's prospects and aligns management interests with shareholders. The immediate vesting is also a positive.
Positives
- The acquisition of shares by a key insider (CEO and Director) signals continued confidence in the company's future prospects.
- The deferred stock units are immediately vested, providing the director with immediate ownership rights.
- The requirement for the director to retain these shares until the completion of Board service aligns management's long-term interests with those of shareholders.
Industry Context
This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.
Related Party Transactions
- The acquisition of 198 common stock shares by Stephen J. Hemsley represents deferred stock units granted as regular quarterly compensation for his service as a director of UnitedHealth Group, which is a transaction between the company and a related party (an executive and director).
Stakeholder Impact
- Shareholders: The acquisition of shares by a key executive may be viewed positively, signaling confidence in the company's future and aligning executive interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| 07/01/2025 | Date of earliest transaction for the acquisition of deferred stock units. |
| 07/02/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Recommendation
holdKeywords
UnitedHealth Group, UNH, Stephen J. Hemsley, Form 4, Insider Transaction, Deferred Stock Units, Director Compensation, Executive Compensation, Stock Acquisition, Healthcare
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.